Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
Journal of Bacteriology|August 1, 1988
Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coliP L Foster, J D Groopman, E EisenstadtCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 5, 2000
Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid-preserved foodsV M Weaver, T Buckley, J D GroopmanCanadian Journal of Physiology and Pharmacology|February 1, 1996
Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancerJ D Groopman, J S Wang, P SchollCancer Research|February 24, 2001
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometryP E Jackson, G S Qian, M D Friesen, et al.Environmental Health Perspectives|July 1, 1998
Approaches to environmental exposure assessment in childrenV M Weaver, T J Buckley, J D GroopmanAnnual Review of Public Health|January 1, 1995
Biomarkers and mechanistic approaches in environmental epidemiologyJ M Links, T W Kensler, J D GroopmanIARC Scientific Publications|January 1, 1996
Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trialsT W Kensler, J D Groopman, G N WoganMutation Research|July 24, 1998
Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and manT W Kensler, J D Groopman, B D RoebuckProgress in Clinical and Biological Research|January 1, 1992
Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat modelsJ D Groopman, B D Roebuck, T W KenslerPageof 13